China Approves First Vaccine for Use in General Population
- Shot is made by state-backed developer China National Biotec
- China has already given more than 4.5 million shots: official
This article is for subscribers only.
China’s drug regulator approved the country’s first coronavirus vaccine for general public use, a sign of confidence in the experimental shots the nation plans to roll out within and beyond its borders.
China’s National Medical Products Administration gave the authorization to a Covid-19 vaccine developed by state-owned China National Biotec Group Co., a unit of Sinopharm, officials told reporters in Beijing Thursday.